• PBM REFORM & REIMBUSEMENT EQUITY

    Pharmacy Middlemen Shouldn’t Decide Who Gets Treatment

    PBMs and insurers are blocking coverage of compounded medications — not because they’re unproven, but because they don’t fit the profit model.

  • Pharmacy Benefit Managers (PBMs) routinely deny reimbursement for compounded medications. They reject claims, set arbitrary exclusions, and lock out compounders from provider networks. That forces patients to pay out of pocket—or go without treatment entirely.

    This is profit-driven gatekeeping, not healthcare.

  • Who’s Paying the Price

    Section image

    Families managing chronic conditions with compounded solutions

    Section image

    Patients priced out of commercial options

    Section image

    Providers forced to change care plans to fit insurance rules

    Section image

    Independent pharmacies competing with vertically integrated giants

  • WHAT NEEDS TO CHANGE

    PBMs must be held accountable for denying legitimate care. That means enforcing transparency, ending discriminatory coverage policies, and giving patients and prescribers the freedom to choose what works.